Journal of Pregnancy

Journal of Pregnancy / 2012 / Article
Special Issue

Basic Experimental and Clinical Advances in the Mechanisms Underlying Abnormal Pregnancy Outcomes

View this Special Issue

Review Article | Open Access

Volume 2012 |Article ID 792934 |

R. E. Fisher, M. Steele, N. A. Karrow, "Fetal Programming of the Neuroendocrine-Immune System and Metabolic Disease", Journal of Pregnancy, vol. 2012, Article ID 792934, 10 pages, 2012.

Fetal Programming of the Neuroendocrine-Immune System and Metabolic Disease

Academic Editor: Timothy Regnault
Received07 Apr 2012
Accepted22 Jul 2012
Published16 Aug 2012


Adverse uterine environments experienced during fetal development can alter the projected growth pattern of various organs and systems of the body, leaving the offspring at an increased risk of metabolic disease. The thrifty phenotype hypothesis has been demonstrated as an alteration to the growth trajectory to improve the survival and reproductive fitness of the individual. However, when the intrauterine environment does not match the extrauterine environment problems can arise. With the increase in metabolic diseases in both Westernized and developing countries, it is becoming apparent that there is an environmental disconnect with the extrauterine environment. Therefore, the focus of this paper will be to explore the effects of maternal malnutrition on the offspring’s susceptibility to metabolic disorders such as obesity, cardiovascular disease, and diabetes with emphasis on programming of the neuroendocrine-immune system.

1. Introduction

Early life events such as those experienced in utero have the ability to shape the phenotype of an individual in an effort to prepare the fetus for extrauterine life. This is typically referred to as developmental or fetal programming and suggests that adverse uterine environments can “permanently” alter the metabolic, endocrine, and immune function parameters of individuals well into adulthood. There appear to be critical windows during development in which the fetus is most sensitive to environmental cues, altering the projected plan of growth. For instance, maternal adversity experienced during gestation will convey signals to the fetus that the environment in which it is to live is less than optimal, altering the developmental programming of the various organs and systems in the body to better match life outside the uterus. As various tissues and systems in the body mature and differentiate at different rates during fetal development, there appear to be critical periods in development when they are most sensitive to this adversity. The hypothalamic-pituitary-adrenal axis (HPAA), for example, undergoes much growth and differentiation during early and late gestation in species such as humans, primates, and sheep, and these are the periods when it is most sensitive to developmental programming alterations [13]. Alterations in metabolic function such as glucose tolerance and insulin sensitivity are greatly affected during mid- and late gestation as metabolic parameters are undergoing much differentiation during this period [4].

The alterations in developmental programming trajectories are assumed to provide an adaptive advantage for the individual to its new environment, referred to as the “thrifty phenotype”. A reduction in birth weight has been one alteration observed following adverse changes in the uterine environment. It is postulated that this alteration in growth pattern allowed the fetus to reallocate the available energy to more vital processes such as organ function [5]. The Leningrad wartime famine cohort of 1941 to 1944 is a classic example of the thrifty phenotype, demonstrating that maternal malnutrition during gestation primed the fetus by repartitioning metabolic energy for life in a malnourished society, ensuring survival and reproductive fitness [6]. However, when the developmental programming does not match the environment in which the individuals are to live, problems can arise.

2. Environmental Mismatch

Adverse uterine environments can occur for a variety of reasons such as maternal under- or overnutrition, maternal illness, or psychological stress that occurs during the critical windows in development. The amount of mismatch between the intrauterine and extrauterine environment can predict the individual’s susceptibility to disease later in life [7]. Barker and colleagues were among the first to discover this association, coining the “Developmental Origins of Health and Disease” (DOHaD) hypothesis. They predicted that babies born with the lowest birth weight had the greatest risk of metabolic disease later in life, indicated by increased incidences of hypertension, obesity, and insulin resistance [810]. This hypothesis implies that adverse events that occur during fetal and neonatal development can increase susceptibility to adulthood diseases such as metabolic disease, although additional associations are being discovered. However, it should also be noted that the postnatal environment such as lifestyle (diet and exercise) as well as genetics play a large role in programming the offspring’s susceptibility to disease; but will not be the focus of this paper.

The Dutch winter famine of 1944-1945 is a classic example of the DOHaD hypothesis. By using records from individuals whose mothers experienced the Dutch winter famine, researchers were able to make associations between individuals who experienced the famine during early gestation and increased susceptibility to hypertension, while those that experienced the famine during late gestation had an increased risk of impaired glucose tolerance and obesity during adulthood [4, 11]. These results emphasized how insults at various time points during gestation can differentially impact the various organs and systems of the body. Although the insult during gestation was the same as the Leningrad cohort, those that experienced the Dutch winter famine are a classic example of an environmental mismatch, as they were born into an environment in which nutrition had become abundant following the termination of war and therefore their metabolic “reprogramming” was deemed unnecessary for the environment in which they were to live.

An environmental mismatch is also becoming apparent in countries such as India as Westernized diets infiltrate the country. Typically, Indian babies are born small, ranging in birth weight between 2.6 and 2.7 kgs, and are thought to have an adaptive thrifty phenotype that is matched to their scarce food environment [1214]. However, India is currently facing an epidemic crisis of adulthood type II diabetes and coronary heart disease (CHD) that is being linked to mismatched fetal and neonatal metabolic programming [15]. Indian children as young as 8 years of age, for example, have increased adiposity and insulin resistance putting them at increased risk of adulthood CHD [12].

Interestingly, this phenotype is also observed in individuals born to obese mothers. The rise in obese individuals in the population and the speculation that 68% of the US adult population has been reported to be obese has sparked interest into its effect on the programming of the fetus [16, 17]. Therefore, it is not surprising that offspring from obese mothers are more susceptible to childhood obesity, hypertension, insulin resistance, and type II diabetes [1821].

Metabolic diseases have recently been classified as inflammatory disorders because they are accompanied by elevated concentrations of proinflammatory cytokines such as IL-1, IL-6, and TNF-α, as well as increased concentrations of glucocorticoids (GCs) in circulation [2224]. Crosstalk between the innate immune system and the neuroendocrine system (i.e., HPAA) play an important role in regulating homeostasis in the body. For example, the excessive nutrients supplied to the hypothalamus in patients with metabolic disease have been implicated in causing inflammation and activation of the hypothalamus. These nutrients have been shown to induce oxidative stress, mitochondrial dysfunction, and stress in the endoplasmic reticulum triggering the activation of proinflammatory kinase pathways such as c-Jun N-terminal kinase (JNK) and inhibitor of B kinase (IKK). Excess nutrients have also been shown to activate Toll-like receptors (TLR) which also lead to the upregulation of JNK and IKK [25]. The increased concentrations of proinflammatory cytokines in individuals with metabolic disease may also act to stimulate the hypothalamus by crossing the blood-brain barrier leading to activation of the JNK and IKK pathways. Subsequent phosphorylation through JNK and IKK pathways leads to the induction of nuclear factors NFκB and AP-1. NFκB is an important regulator of inflammatory response genes leading to the activation of numerous proinflammatory cytokines, cytokine receptors as well as suppressor cytokine signaling 3 (SOC3), cyclooxgenase-2 (COX-2), and lipoxygenase [22]. Additionally, activation of the hypothalamus by these various mechanisms will also trigger the release of adrenal GCs. GCs play an important role in regulating the homeostasis in the body. GCs are released from the adrenal gland following activation of the HPAA. Briefly, during periods of perceived threats the HPAA becomes activated in order to achieve homeostasis. Once the body has recognized the threat it acts by secreting two neuropeptides corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) from the hypothalamus. These neuropeptides are then secreted into the hypophyseal portal to activate the pituitary for the production of adrenocorticotropin hormone (ACTH) from the anterior pituitary. Once produced ACTH can travel through the circulation to the adrenal cortex to activate the production of GCs. GCs play many important roles in the body from regulating fetal growth and development, mobilizing glucose and fat stores, controlling inflammation, and modulating the immune response [2628]. Therefore, fetal programming-induced alterations in any aspect of these pathways have the ability to alter metabolic function leaving individuals susceptible to a variety of adult metabolic disorders.

Although metabolic diseases such as obesity, diabetes, and even cardiovascular disease have gained much attention in connection with the DOHaD hypothesis, various other diseases and disorders such as allergies, asthma, Alzheimer’s disease, and psychological disorders are now also being linked with adverse uterine environments, although not covered in this paper. Therefore, the focus of this paper will be to examine the incidences and hypothesized mechanisms surrounding fetal programming of metabolic disorders.

3. Metabolic Disease

Metabolic disease encompasses a variety of different disorders, such as obesity, cardiovascular disease (CVD), and type II diabetes. With CVD and type II diabetes among the top ten leading causes of death in the United States, it is apparent that metabolic disease is quickly becoming an epidemic in the Westernized as well as the developing countries [29]. As metabolic diseases continue to climb within the world population, focus is being placed on their association with adverse uterine environments. Metabolic diseases were among the first recognized disorders associated with adverse uterine environments. Barker and colleagues first made this association by examining poverty stricken areas of England and Wales between 1968 and 1978, linking those individuals born with low birth weight to having an increased susceptibility to CHD as adults [30]. These associations were also confirmed through examination of individuals that lived through the Dutch famine of 1944-1945.

The Dutch famine provided a unique opportunity to examine the effect of undernutrition during different periods of gestation on the susceptibility to adulthood disease. Individuals born during the famine were typically lighter, shorter, and thinner than babies that were not exposed, representing an intrauterine growth restricted (IUGR) phenotype [31]. One of the concerns with IUGR individuals is that they may experience “catch-up” growth when exposed to an abundance of nutrition. Catch-up growth has been thought of as an adaptive survival mechanism, however, the long-term activation of both the growth and neuroendocrine systems increases the risk of metabolic diseases in adulthood [32]. For example, adults who were exposed to the famine during mid- or late gestation showed reduced glucose toleration, while those exposed during early gestation were shown to have a greater atherogenic lipid profile, higher body mass index (BMI), and a greater risk of CHD [3336]. Type II diabetes was also more prevalent among the individuals who were exposed to the famine in utero, marked by reduced glucose tolerance and raised insulin concentrations among middle-age individuals [36, 37]. In support of this hypothesis recent work has demonstrated that children who were born small for gestational age (SGA) and experienced catch-up growth without obesity had higher rates of insulin resistance than children born appropriate for gestational age, suggesting that it is the uterine programming itself that influences the future outcome of disease [38]. Therefore, these studies suggest that alterations in uterine environment can influence the individual’s susceptibility to metabolic disease on into adulthood; this will be more closely examined below.

4. Obesity

Ironically, both maternal under- and overnutrition has been shown to result in a similar obese offspring phenotype. This is becoming more and more apparent in developing countries such as India [39]. It has been discovered that although these children are born with the lowest birth weight, they have the smallest abdominal circumference, and a normal head circumference, they also surprisingly have the thickest skin-fold measurements suggesting that these babies are thin but with the greatest distribution of fat [40]. Work from Yajnik and colleagues [40] has shown that Indian babies tend to deposit fat tissue during development but have relatively poor tissue growth and protein turnover. What is of greatest concern, however, is that these children appear to retain this adiposity throughout childhood and into adulthood which could increase their susceptibility to other metabolic disorders [41].

Over the past few years overnutrition in both Westernized societies and developing countries has also become a concern as it is altering the metabolic programming of individuals making them more susceptible to obesity. With approximately two-thirds of American women being overweight, research is desperately needed in order to understand and prevent detrimental programming of the fetus [42]. Typically, offspring of obese mothers are born large and tend to have increased adiposity, making them further susceptible to metabolic diseases [43]. It has been speculated that maternal transfer of lipids is altered during an obesogenic pregnancy, often resulting in an earlier increase in lipid transfer compared to that of the pregnancy of a lean woman [44]. Briefly, in normal pregnancies, lipogenesis is greatest during early gestation in order to accumulate the fat stores required for a successful pregnancy [45]. Since obese mothers do not need to accumulate as many fat stores as leaner mothers, the process of lipid mobilization occurs much earlier in gestation and this means that more lipids can reach the fetus and this affects the programming of many organs and systems in the body associated with metabolism [44]. Additionally, the pregnancy of obese women has been shown to increase the hydrolysis of triglycerides and the concentration of free fatty acids as well as their transport across the placenta, once again leading to an increase in lipid exposure to the fetus [44]. Not surprisingly, the placentas from obese mothers also tend to support a proinflammatory environment as exhibited by increased expression of proinflammatory cytokines IL-1, TNF-α, and IL-6, as well as an increase in the accumulation of macrophages [46]. A recent study by Hayes and colleagues, [47], also demonstrated that an unfavourable uterine environment in rat dams fed a high-fat diet during pregnancy altered the placental vasculature which led to increased hypoxia during gestation, affecting not only the health of the offspring but also their viability. Under normal circumstances pregnancy is considered an inflammatory event associated with proinflammatory cytokines infiltrating the placenta. However, these cytokines are further increased in the obese mothers potentially due to the increase in both leptin and insulin concentrations [48]. Additionally, obese woman have an increase in the expression of CD14+ and CD68+ cells; two markers that define macrophages, and support the observed increase in proinflammatory cytokines [48]. The mechanisms behind placental lipid transport in obese pregnancies are generally understood; however, the mechanisms behind how it influences the fetal programming of metabolic states are generally not known.

The hypothalamus appears to be quite sensitive to nutritional programming as demonstrated through various animal models. This is not surprising as the hypothalamus houses the arcuate nucleus that contains the neurons for stimulating and suppressing appetite. Neurons containing neuropeptide Y (NPY) and GABA are found in the arcuate nucleus and are important in regulating appetite behaviour. Leptin and insulin, however, can inhibit the hormones of these neurons, thereby, suppressing an individual’s appetite. Therefore, alterations in hormones and their receptors of this region of the hypothalamus can have a profound influence on the appetite behaviour of the individual. Alterations in the functioning of the leptin receptors as well as its secretion have been associated with obesity, overeating, and other metabolic diseases. For example, maternal high-fat diets have been demonstrated to induce leptin resistance in the hypothalamus of rat offspring, which led to an increase in body-weight gain during adulthood [49]. Other studies have also demonstrated increased concentrations of leptin in circulation of rats born to calorie-restricted mothers leading to leptin resistances and alterations in their feeding behaviour [50]. Additionally, male offspring born to the calorie-restricted mothers tended to consume more calories and gain more weight than control offspring [50]. The authors suggest that these effects could be explained by the lack of leptin surge that is normally observed between 6–14 days of postnatal development that is responsible for developing and differentiating the appetite control pathways in the hypothalamus. Other studies also support these findings as the mRNA expression levels of the leptin receptor in the hypothalamus of female rats born to mothers fed a high fat diet have been shown to increase, which is thought to be one reason for the observed increase in leptin levels [51]. However, it should also be noted that obese mothers or mothers with gestational diabetes have a higher concentrations of leptin in circulation that can reach the fetus affecting their programming [52].

The high level of triglycerides has also been proposed to play a role in altering the leptin profile of the fetus and increasing their susceptibility to adulthood disease. Studies have found that offspring leptin levels dramatically decline following parturition, possibly due to the higher concentration of maternal triglycerides in circulation [52]. Triglycerides have been shown to limit the amount of leptin crossing the fetal blood-brain barrier, creating somewhat of a leptin deficiency in these offspring [52]. This is concerning as studies have found that offspring with low postnatal leptin levels also tend to deposit fat tissue faster and gain more weight during lactation compared to their control counterparts [53].

Other studies have also reported changes in the STAT-3 pathway affecting the production of leptin [54]. The effects of leptin on other appetite controlling proteins such as neuropeptide Y are controlled through STAT-3. Briefly, once leptin is released from the adipose cell, it travels through circulation across the blood-brain barrier to bind to the leptin receptor in the hypothalamus. The intracellular domain of the leptin receptor can then bind to the STAT-3 resulting in its phosphorylation and activation of SOCS3 [55]. SOCS3 becomes an important regulator of the pathway, as it is capable of working through a negative feedback loop to downregulate the expression of leptin. Alterations in the STAT-3 pathway have been implicated in leptin resistance, which is commonly observed in obese individuals. Researchers have found significant decreases in the protein level of STAT-3 in the female rats from obese mothers, regardless of an increase in mRNA expression of STAT-3 and therefore alterations in this signal transduction pathway may affect appetite control [51].

Glucocorticoids have also been shown to be involved in fetal programming caused by maternal malnutrition. Higher levels of maternal GCs, for example, have been observed following gestational malnutrition, resulting in an increased concentration of GCs reaching the fetus and altering the HPAA programming [56, 57]. In a recent study by Belkacemi and colleagues [56], it was observed that undernourished rat dams had increased levels of plasma GCs in comparison to the control dams and this was accompanied by a reduction in fetal and placental weights. Furthermore, it was observed that there was an increased expression of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) type 1 in the labyrinth zone of the placenta and a reduction in the expression of 11beta-HSD type 2, suggesting that there is an upregulation of active cortisol reaching the fetus [56]. An increase in GCs reaching the fetus has been associated with hypoleptinaemia and therefore may be one mechanism by which the hypothalamus is being reprogrammed [58, 59]. Interestingly, high-fat diets coupled with maternal stress appear to further exacerbate weight gain in rat offspring [60]. Offspring demonstrated an increased adiposity and a reduction in lean mass when their mother was fed a high-fat diet and stressed during gestation compared to offspring born to mothers fed the high-fat diet alone [60]. This trend continued following weaning with offspring experiencing a greater amount of weight gain compared to the control offspring. This is not surprising as GCs have been shown to increase the synthesis of endocannabinoids and their receptors, resulting in an increased appetite [61]. On the other hand leptin has been shown to block the endocannabinoid receptor downregulating appetite. Therefore, it appears that GCs and a high-fat diet may be working synergistically preventing leptin inhibition of this receptor. Overall, it is apparent that maternal under- and overnutrition play a large role in the development of the obesogenic phenotype. What is most concerning is that the obese phenotype observed in the offspring not only affects their overall quality of life but also increases their susceptibility to other metabolic disorders such as cardiovascular disease (CVD) and diabetes.

5. Cardiovascular Disease (CVD)

Cardiovascular disease was one of the first recognized disorders associated with adverse uterine environments. Fetally programmed individuals are more susceptible to hypertension and CHD and develop these disorders at much younger ages. For example, it was demonstrated using a rat model that offspring born to protein-restricted mothers had elevated systolic and diastolic blood pressures as early as four weeks of age, suggesting early development of CVD [62].

An increase in the occurrence of hypertension is commonly observed in offspring that were subjected to malnutrition during gestation. Individuals who were small for gestational age (SGA) at birth have been shown to have increases in blood pressure throughout childhood and adulthood, a trend that is interestingly not carried forward throughout adolescence [63]. In a recent study by Khoury and colleagues [64], it was demonstrated that waist-to-height ratios need to be considered when examining the susceptibility to hypertension and metabolic disease, as those individuals with increased weight-to-height ratios had greater adiposity and were more at risk of developing hypertension. It has been suggested that increased elasticity in vessel walls as well as alterations in placental enzyme 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) may also be behind the increase in the susceptibility to hypertension [63, 65].

Glucorticoids as mentioned earlier, are typically elevated in mothers exposed to some degree of malnutrition during gestation, which increase fetal exposure to GCs [66, 67]. GCs play an important role in regulating cardiovascular function creating an environment that favours tissue sensitivity to vasoactive hormones [68]. GC actions are regulated by the enzyme 11beta-HSD, either promoting the active form of cortisol through enzymatic actions of 11beta-HSD1 or rendering cortisol inactive through 11beta-HSD2. The enzyme 11beta-HSD2 is an important regulator during pregnancy and is found in abundance at the level of the placenta where it protects the fetus from an overexposure to maternal GCs by rendering them inactive before they have the chance to cross the placental barrier. However, studies examining the effect of malnutrition on the development of offspring have demonstrated an inhibition in the activity of 11beta-HSD2 at the level of the placenta [67, 69]. In fact rat offspring born to mothers subjected to low-protein diets during gestation often exhibit an increase in glucocorticoid receptor (GR) expression and an attenuation in 11beta-HSD2 expression in various tissues of the body, such as the kidney, liver, and lungs which can be upwards of a two-fold increase compared to the control offspring [65]. Another research group has shown that dexamethasone administration to pregnant ewes in early pregnancy leads to reprogramming of the HPAA in the offspring, making them susceptible to hypertension approximately 5 years after the point of insult [70]. The impairment in both GR and 11beta-HSD2 in malnutrition-programmed individuals have the potential to influence sodium uptake, fluid-electrolyte homeostasis, and vascular tone; all of which have the potential to promote a favourable environment for hypertension in adulthood [65, 71, 72].

Subsequent studies have also demonstrated alterations in the renal-angiotensin system of offspring born to malnourished mothers. The renin-angiotensin system is an important regulator of cardiac function more specifically blood vessel constriction. Briefly, renin is a catalytic enzyme overseeing the conversion of angiotensinogen to angiotensin I, and subsequently angiotensin II. Angiotensin II is a potent vasoconstrictor leading to an increase in blood pressure, as well as the stimulation of aldosterone from the adrenal gland, which acts to increase the reabsorption of sodium and water. Maternal malnutrition has been shown to cause alterations in the gene and protein expression in many of the components of this system. For example, there is a decrease in both angiotensin I and II receptors in the kidneys of offspring born to low-protein-supplemented mothers [73]. When rat pups experienced IUGR due to maternal caloric restriction during gestation there was a significant upregulation in the angiotensin II in the kidney as well as a reduction in kidney weight [74, 75]. Therefore, it is not surprising that there are also increases in the angiotensin-converting-enzyme (ACE) and angiotensin-converting-enzyme 2 (ACE2) in rat offspring from undernourished mothers [75]. The increase in expression in both the enzyme and hormones responsible for vasoactivity nurture an environment supporting the grounds for hypertension. Alterations in the genes involved in sodium regulation such as renal Na/K-ATPase-alpha1 have also been observed to be affected by maternal malnutrition in the rat model; supporting the observation of elevated levels of renal Na/K-ATPase-alpha1 expression, in the offspring rats born to dexamethasone challenged mothers [76]. Similar results have been observed in sheep demonstrating a reduction in nephron number as well as alterations in the renin-angiotensin system of the brain [70]. Taken together these studies demonstrate associations between fetal programming of the renin-angiotensin system and the development of hypertension.

Placental insufficiency has also been shown to increase the susceptibility to adulthood CHD. In a cohort out of Helsinki Finland it was observed that individuals whose placenta measured less than 225 cm2 had an odds ratio of developing chronic heart failure if 1.7 compared to those individuals who had a normal placental distribution [77]. The odds were further increased in these individuals if the individual experienced rapid body-weight gain after the age of 2 and an increased body mass index at 11 years of age [77]. This seems to be further emphasized in the male population of the Helsinki cohort. When males were born SGA and remained small in infancy but had accelerated weight gain later in life, they had the greatest odds of developing CHD compared to the control men [78]. Similar results have been observed in a population of low and high birth weight boys. It was observed that boys who were born with a below-average ponderal index and rapid weight gain during childhood had a high rate of CHD among the study population; however, those boys who were born with an above-average ponderal index and experienced rapid weight gain during childhood did not show an association with CHD [79].

The increase in proinflammatory cytokines in obese individuals has also been shown to play a role in the development of CVD. For example, IL-1, IL-6, and TNF-α have been found to be increased in the circulation of obese people, which is not surprising as both have also been found to be produced in the adipose tissue [80]. Both cytokines promote an insulin resistant, high-triglyceride environment resulting in increased blood pressure and potentially CHD [81]. These cytokines have also been shown to increase the formation of plaque in the development of atherosclerosis as well as furthering the progression of the disease [82]. Furthermore, the amount of free fatty acids and TNF-α present in circulation of obese individuals increase the adhesion of monocytes to the endothelial monolayer which authors suggest could be influencing the inflammatory process and dictating the early development of artherosclerosis [83].

Lastly, fetal hypoxia has been shown to be associated with cardiovascular disease. As mentioned earlier, maternal obesity can lead to hypoxic conditions in the labyrinth of the placenta [47]. These hypoxic changes have the ability to alter the cardiovascular function in the offspring. For example, rats that were exposed to in utero hypoxic conditions demonstrated an increased susceptibility to ischaemia-reperfusion injury as adults [84]. Additionally, the cardiomyocytes of these rats were also enlarged with fewer numbers found in the heart [84]. In a recent study, increased likelihood of ischaemic injury caused by fetal hypoxia has been associated with an increase in the gene expression of angiotensin type II receptor (AT(2)R) in the rat [85]. Interestingly, there was a 50% decrease in the GR binding to glucocorticoid response elements in the AT(2)R promoter region in the hearts of these offspring [85]. Authors suggest that epigenetic mechanisms may be at play; however, the exact mechanisms are still unknown.

Overall, fetal programming appears to increase the susceptibility to cardiovascular disease. Although the exact mechanisms are unknown it is becoming clearer that both physiological mechanisms as well as alterations in genetic components are at play.

6. Type II Diabetes

Diabetes is also programmed by both over- and undernutrition and is currently reaching epidemic levels worldwide. Insulin sensitivity and resistance appears to be influential in the development of glucose tolerance and ultimately type II diabetes. Insulin sensitivity has been shown in many models of fetal origins of disease and appears to be a quite common consequence of malnutrition during gestation. Many of the studies of children who were born SGA have demonstrated a reduction in insulin sensitivity following a period of rapid catch-up growth during childhood. Insulin sensitivity in these children usually occurs in the presence of other factors such as increased adiposity and hypercholesterolemia [12, 86, 87]. Rapid catch-up growth appears to be one of the determining factors behind the development of insulin resistance in children born SGA. Children born in the Danish cohort study and who experienced rapid weight gain from birth to three months of age had higher insulin resistance at 1 year of age and higher basal insulin concentrations at 17.6 years of age, demonstrating that this alteration in metabolism is maintained [88]. Similarly, insulin concentrations were also observed to be higher in a cohort of healthy individuals born SGA compared to AGA [89]. Additionally, insulin resistance has also been shown to occur during fetal development in obese women compared to that of lean women suggesting that metabolic alterations are already apparent at the time of birth [90].

Various molecular mechanisms have been suggested for the increased susceptibility to insulin resistance and type II diabetes. For example, beta-cell development appears to be impaired following caloric restriction during pregnancy; this is exacerbated to the point of a permanent reduction in function if the mother is further restricted during lactation [91]. Similarly, rats whose mothers were fed a high-fat diet throughout gestation also demonstrated impairment in the beta-cell function, which was exacerbated in the female offspring compared to the males [92]. Epigenetic alterations have also been shown to be associated with reduction in beta-cell mass due to hypomethylation in the GR gene increasing the sensitivity to GCs [93]. Additionally, the promoter region of the PDX-1 gene, important for the normal differentiation of the beta cells, has been shown to undergo deacetylation at the histone complexes altering beta-cell development in IUGR rat pups [94]. Abnormalities in mitochondria may be to blame for these alterations in islet function. Mitochondria are imperative in the detection of glucose by beta cells and therefore alterations in their function can lead to impairments in this system [92, 95]. Gestational diabetes appears to further increase the susceptibility of type II diabetes in the offspring by targeting the beta cells [96]. Gestational diabetes also shows morphological impairment of the islets in the offspring, demonstrated through abnormal islet shape as well as hyperplasia and hypertrophy [97].

Islet function was also shown to be impaired in this rodent model [92]. Under normal circumstances islets increase the release of insulin upon an increase in the concentration of glucose found in the body. However, offspring born to both nutrient-restricted and high-fat supplemented mothers did not show an increase in insulin release following glucose stimulation indicating impairment in their function [92]. Glucose-stimulated insulin secretion was also impaired in islets from 9-month-old offspring born to dams that were fed a high-fat diet throughout gestation [98]. This study also revealed a reduction in expression of the mitochondrial genome in various tissues of the offspring.

Additionally, maternal obesity or high-fat diet during pregnancy has been associated with inflammation in the hypothalamus of the offspring, altering the TLR4 signaling cascade and increasing the offspring’s susceptibility to diabetes. When TLR4 becomes activated following ligand binding, it subsequently activates both JNK and IKK pathways. Through multiple phosphorylation events in the IKK pathway NFκB is produced from IκB, which promotes the transcription of proinflammatory cytokines [99]. On the other hand phosphorylation of JNK will lead to the inhibition of insulin receptor substrate 1 (IRS-1) and ultimately insulin resistance in the host [100]. Therefore, these pathways play an important role in the development of insulin resistance and diabetes, and tend to be quite sensitive to fetal programming through maternal malnutrition. For example, a mouse study demonstrated that when dams were fed a high-fat diet from conception to weaning, their offspring had increased activation of JNK 1 and IkB kinase [101]. Additionally, tissue samples collected from rats fed a Westernized diet demonstrated an increase in insulin resistances in tissues that had the greatest JNK activity and IRS-1 phosphorylation [102]. Although the mechanisms by which alterations in the TLR4 signaling cascade can lead to insulin resistance and type II diabetes is not known, it is becoming increasingly apparent that it plays a role in the susceptibility. A mouse strain, CeH/HeJ, further supports this idea, as these mice have a mutation causing loss of function in TLR4 protecting them from diet-induced obesity and insulin resistance [103, 104].

Therefore, it appears that the intrauterine environment can increase the susceptibility of diabetes later in life due to alterations in insulin sensitivity and changes in beta-cell expression and mass.

7. Summary

It is becoming more apparent that adulthood metabolic disease is associated with adverse uterine environments. Although adversity is thought to prime the offspring for life outside the uterus the diverse phenotypes in the offspring from malnourished mothers is increasing their susceptibility to adulthood metabolic diseases such as obesity, CVD, and diabetes. With metabolic disorders reaching epidemic levels in the world population, future research is required in order to understand the underlying mechanisms leading to alterations in the programming of the fetus and subsequent development of adulthood disease. What is apparent is that the neuroendocrine-immune system interactions play a key role in the development of metabolic disease. With an increase in knowledge of these interactions future emphasis can be placed on the treatment and prevention of metabolic disorders of fetal origin.


  1. S. E. Chadio, B. Kotsampasi, G. Papadomichelakis et al., “Impact of maternal undernutrition in the hypothalamic-pituitary-adrenal axis responsiveness in sheep at different ages postnatal,” Journal of Endocrinology, vol. 192, no. 3, pp. 495–503, 2007. View at: Publisher Site | Google Scholar
  2. F. H. Bloomfield, M. H. Oliver, C. D. Giannoulias, P. D. Gluckman, J. E. Harding, and J. R. G. Challis, “Brief undernutrition in late-gestation sheep programs the hypothalamic-pituitary-adrenal axis in adult offspring,” Endocrinology, vol. 144, no. 7, pp. 2933–2940, 2003. View at: Publisher Site | Google Scholar
  3. R. E. Fisher, N. A. Karrow, M. Quinton et al., “Endotoxin exposure during late pregnancy alters ovine offspring febrile and hypothalamic-pituitary-adrenal axis responsiveness later in life,” Stress, vol. 13, no. 4, pp. 334–342, 2010. View at: Publisher Site | Google Scholar
  4. A. C. J. Ravelli, J. H. P. Van Der Meulen, C. Osmond, D. J. P. Barker, and O. P. Bleker, “Obesity at the age of 50 y in men and women exposed to famine prenatally,” American Journal of Clinical Nutrition, vol. 70, no. 5, pp. 811–816, 1999. View at: Google Scholar
  5. P. D. Gluckman, W. Cutfield, P. Hofman, and M. A. Hanson, “The fetal, neonatal, and infant environments-the long-term consequences for disease risk,” Early Human Development, vol. 81, no. 1, pp. 51–59, 2005. View at: Publisher Site | Google Scholar
  6. C. N. Hales and D. J. P. Barker, “The thrifty phenotype hypothesis,” British Medical Bulletin, vol. 60, pp. 5–20, 2001. View at: Publisher Site | Google Scholar
  7. M. H. Vickers, “Developmental programming of the metabolic syndrome—critical windows for intervention,” The World Journal of Diabetes, vol. 2, no. 9, pp. 137–148, 2011. View at: Google Scholar
  8. D. J. P. Barker, P. D. Winter, C. Osmond, B. Margetts, and S. J. Simmonds, “Weight in infancy and death from ischaemic heart disease,” Lancet, vol. 2, no. 8663, pp. 577–580, 1989. View at: Google Scholar
  9. D. J. P. Barker, A. R. Bull, C. Osmond, and S. J. Simmonds, “Fetal and placental size and risk of hypertension in adult life,” British Medical Journal, vol. 301, no. 6746, pp. 259–262, 1990. View at: Google Scholar
  10. C. Osmond, D. J. P. Barker, and J. M. Slattery, “Risk of death from cardiovascular disease and chronic bronchitis determined by place of birth in England and Wales,” Journal of Epidemiology and Community Health, vol. 44, no. 2, pp. 139–141, 1990. View at: Google Scholar
  11. C. M. Law, D. J. P. Barker, C. Osmond, C. H. D. Fall, and S. J. Simmonds, “Early growth and abdominal fatness in adult life,” Journal of Epidemiology and Community Health, vol. 46, no. 3, pp. 184–186, 1992. View at: Google Scholar
  12. A. Bavdekar, C. S. Yajnik, C. H. D. Fall et al., “Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?” Diabetes, vol. 48, no. 12, pp. 2422–2429, 1999. View at: Google Scholar
  13. C. Gopalan, “Child care in India: emerging challenges,” Yojana, vol. 37, no. 10, pp. 6–8, 1993. View at: Google Scholar
  14. M. Mohan, S. R. Prasad, H. K. Chellani, and V. Kapani, “Intrauterine growth curves in north Indian babies: weight, length, head circumference and ponderal index,” Indian Pediatrics, vol. 27, no. 1, pp. 43–51, 1990. View at: Google Scholar
  15. R. Gupta and V. P. Gupta, “Meta-analysis of coronary heart disease prevalence in India,” Indian Heart Journal, vol. 48, no. 3, pp. 241–245, 1996. View at: Google Scholar
  16. K. M. Flegal, C. L. Ogden, J. A. Yanovski et al., “High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group,” American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1020–1026, 2010. View at: Publisher Site | Google Scholar
  17. M. Z. Alfaradhi and S. E. Ozanne, “Developmental programming in response to maternal overnutrition,” Frontiers in Genetics, vol. 2, article 27, 2011. View at: Google Scholar
  18. M. A. Pufal, C. C. Moulin, D. S. Casagrande et al., “Prevalence of overweight in children of obese patients: a dietary overview,” Obesity Surgery, vol. 22, no. 8, pp. 1220–1224, 2012. View at: Google Scholar
  19. E. Colín-Ramírez, L. Castillo-Martínez, A. Orea-Tejeda, A. R. Villa Romero, A. V. Castañeda, and E. Asensio Lafuente, “Waist circumference and fat intake are associated with high blood pressure in mexican children aged 8 to 10 years,” Journal of the American Dietetic Association, vol. 109, no. 6, pp. 996–1003, 2009. View at: Publisher Site | Google Scholar
  20. M. E. Symonds, M. Pope, D. Sharkey, and H. Budge, “Adipose tissue and fetal programming,” Diabetologia, vol. 55, no. 6, pp. 1597–1606, 2012. View at: Google Scholar
  21. A. Ornoy, “Prenatal origin of obesity and their complications: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia,” Reproductive Toxicology, vol. 32, no. 2, pp. 205–212, 2011. View at: Publisher Site | Google Scholar
  22. D. Cai and T. Liu, “Hypothalamic inflammation: a double-edged sword to nutritional diseases,” Annals of the New York Academy of Sciences, vol. 1243, pp. E1–E39, 2011. View at: Google Scholar
  23. T. W. Weiss, I. Seljeflot, E. M. Hjerkinn, and H. Arnesen, “Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease,” International Journal of Clinical Practice, vol. 65, no. 9, pp. 939–944, 2011. View at: Google Scholar
  24. J. N. Fain, “Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells,” Vitamins and Hormones, vol. 74, pp. 443–477, 2006. View at: Publisher Site | Google Scholar
  25. A. Kleinridders, D. Schenten, A. C. Könner et al., “MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity,” Cell Metabolism, vol. 10, no. 4, pp. 249–259, 2009. View at: Publisher Site | Google Scholar
  26. F. Ramírez, D. J. Fowell, M. Puklavec, S. Simmonds, and D. Mason, “Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro,” Journal of Immunology, vol. 156, no. 7, pp. 2406–2412, 1996. View at: Google Scholar
  27. L. E. Jensen and A. S. Whitehead, “Regulation of serum amyloid A protein expression during the acute-phase response,” Biochemical Journal, vol. 334, part 3, pp. 489–503, 1998. View at: Google Scholar
  28. C. Carter-Su and K. Okamoto, “Effect of insulin and glucocorticoids on glucose transporters in rat adipocytes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 252, no. 4, part 1, pp. E441–E453, 1987. View at: Google Scholar
  29. M. Heron, “Deaths: leading causes for 2007,” National Vital Statistics Reports, vol. 59, no. 8, pp. 1–95, 2011. View at: Google Scholar
  30. D. J. P. Barker, “In utero programming of chronic disease,” Clinical Science, vol. 95, no. 2, pp. 115–128, 1998. View at: Google Scholar
  31. T. J. Roseboom, J. H. P. Van der Meulen, A. C. J. Ravelli, C. Osmond, D. J. P. Barker, and O. P. Bleker, “Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview,” Molecular and Cellular Endocrinology, vol. 185, no. 1-2, pp. 93–98, 2001. View at: Publisher Site | Google Scholar
  32. E. J. Crespi, “A mechanistic understanding of ageing revealed by studying the young,” Molecular Ecology, vol. 21, no. 6, pp. 1307–1310, 2012. View at: Google Scholar
  33. A. C. Ravelli, O. P. Bleker, T. J. Roseboom, G. A. van Montfrans, C. Osmond, and D. J. Barker, “Cardiovascular disease in survivors of the Dutch famine,” Nestlé Nutrition Institute Workshop Series: Pediatric Program, vol. 55, pp. 183–195, 2005. View at: Google Scholar
  34. T. J. Roseboom, J. H. P. Van der Meulen, C. Osmond, D. J. P. Barker, A. C. J. Ravelli, and O. P. Bleker, “Plasma lipid profiles in adults after prenatal exposure to the Dutch famine,” American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1101–1106, 2000. View at: Google Scholar
  35. T. J. Roseboom, J. H. P. van der Meulen, C. Osmond et al., “Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45,” Heart, vol. 84, no. 6, pp. 595–598, 2000. View at: Google Scholar
  36. A. C. J. Ravelli, J. H. P. Van Der Meulen, R. P. J. Michels et al., “Glucose tolerance in adults after prenatal exposure to famine,” Lancet, vol. 351, no. 9097, pp. 173–177, 1998. View at: Publisher Site | Google Scholar
  37. S. R. De Rooij, R. C. Painter, D. I. Phillips et al., “Impaired insulin secretion after prenatal exposure to the Dutch famine,” Diabetes Care, vol. 29, no. 8, pp. 1897–1901, 2006. View at: Publisher Site | Google Scholar
  38. O. Sancakli, F. Darendeliler, F. Bas et al., “Insulin, adiponectin, IGFBP-1 levels and body composition in small for gestational age born non-obese children during prepubertal ages,” Clinical Endocrinology, vol. 69, no. 1, pp. 88–92, 2008. View at: Publisher Site | Google Scholar
  39. C. S. Yajnik, “Obesity epidemic in India: intrauterine origins?” Proceedings of the Nutrition Society, vol. 63, no. 3, pp. 387–396, 2004. View at: Publisher Site | Google Scholar
  40. C. S. Yajnik, C. H. D. Fall, K. J. Coyaji et al., “Neonatal anthropometry: the thin-fat Indian baby. The Pune maternal nutrition study,” International Journal of Obesity, vol. 27, no. 2, pp. 173–180, 2003. View at: Publisher Site | Google Scholar
  41. C. S. Yajnik, C. V. Joglekar, A. N. Pandit et al., “Higher offspring birth weight predicts the metabolic syndrome in mothers but not fathers 8 years after delivery: the Pune children's study,” Diabetes, vol. 52, no. 8, pp. 2090–2096, 2003. View at: Publisher Site | Google Scholar
  42. Y. Yogev and P. M. Catalano, “Pregnancy and obesity,” Obstetrics and Gynecology Clinics of North America, vol. 36, no. 2, pp. 285–300, 2009. View at: Publisher Site | Google Scholar
  43. C. M. Boney, A. Verma, R. Tucker, and B. R. Vohr, “Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus,” Pediatrics, vol. 115, no. 3, pp. e290–e296, 2005. View at: Publisher Site | Google Scholar
  44. M. J. R. Heerwagen, M. R. Miller, L. A. Barbour, and J. E. Friedman, “Maternal obesity and fetal metabolic programming: a fertile epigenetic soil,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 299, no. 3, pp. R711–R722, 2010. View at: Publisher Site | Google Scholar
  45. K. Y. Lain and P. M. Catalano, “Metabolic changes in pregnancy,” Clinical Obstetrics and Gynecology, vol. 50, no. 4, pp. 938–948, 2007. View at: Publisher Site | Google Scholar
  46. J. C. Challier, S. Basu, T. Bintein et al., “Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta,” Placenta, vol. 29, no. 3, pp. 274–281, 2008. View at: Publisher Site | Google Scholar
  47. E. K. Hayes, A. Lechowicz, J. J. Petrik et al., “Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature,” PLoS One, vol. 7, no. 3, article e33370, 2012. View at: Google Scholar
  48. J. C. Challier, S. Basu, T. Bintein et al., “Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta,” Placenta, vol. 29, no. 3, pp. 274–281, 2008. View at: Publisher Site | Google Scholar
  49. J. Férézou-Viala, A. F. Roy, C. Sérougne et al., “Long-term consequences of maternal high-fat feeding on hypothalamic leptin sensitivity and diet-induced obesity in the offspring,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 293, no. 3, pp. R1056–R1062, 2007. View at: Publisher Site | Google Scholar
  50. M. Palou, J. Konieczna, J. M. Torrens et al., “Impaired insulin and leptin sensitivity in the offspring of moderate caloric-restricted dams during gestation is early programmed,” The Journal of Nutritional Biochemistry. In press. View at: Google Scholar
  51. A. Gupta, M. Srinivasan, S. Thamadilok, and M. S. Patel, “Hypothalamic alterations in fetuses of high fat diet-fed obese female rats,” Journal of Endocrinology, vol. 200, no. 3, pp. 293–300, 2009. View at: Publisher Site | Google Scholar
  52. W. A. Banks, A. B. Coon, S. M. Robinson et al., “Triglycerides induce leptin resistance at the blood-brain barrier,” Diabetes, vol. 53, no. 5, pp. 1253–1260, 2004. View at: Publisher Site | Google Scholar
  53. M. J. Morris and H. Chen, “Established maternal obesity in the rat reprograms hypothalamic appetite regulators and leptin signaling at birth,” International Journal of Obesity, vol. 33, no. 1, pp. 115–122, 2009. View at: Publisher Site | Google Scholar
  54. K. El-Haschimi, D. D. Pierroz, S. M. Hileman, C. Bjørbæk, and J. S. Flier, “Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity,” Journal of Clinical Investigation, vol. 105, no. 12, pp. 1827–1832, 2000. View at: Google Scholar
  55. G. Frühbeck, “Intracellular signalling pathways activated by leptin,” Biochemical Journal, vol. 393, no. 1, pp. 7–20, 2006. View at: Publisher Site | Google Scholar
  56. L. Belkacemi, A. Jelks, C. H. Chen, M. Ross, and M. Desai, “Altered placental development in undernourished rats: role of maternal glucocorticoids,” Reproductive Biology and Endocrinology, vol. 9, article 105, 2011. View at: Publisher Site | Google Scholar
  57. J. Lesage, B. Blondeau, M. Grino, B. Bréant, and J. P. Dupouy, “Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat,” Endocrinology, vol. 142, no. 5, pp. 1692–1702, 2001. View at: Publisher Site | Google Scholar
  58. M. C. Sugden, M. L. Langdown, M. J. Munns, and M. J. Holness, “Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring,” European Journal of Endocrinology, vol. 145, no. 4, pp. 529–539, 2001. View at: Google Scholar
  59. J. T. Smith and B. J. Waddell, “Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids,” Endocrinology, vol. 144, no. 7, pp. 3024–3030, 2003. View at: Publisher Site | Google Scholar
  60. K. L. K. Tamashiro and T. H. Moran, “Perinatal environment and its influences on metabolic programming of offspring,” Physiology and Behavior, vol. 100, no. 5, pp. 560–566, 2010. View at: Publisher Site | Google Scholar
  61. R. Malcher-Lopes, S. Di, V. S. Marcheselli et al., “Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release,” Journal of Neuroscience, vol. 26, no. 24, pp. 6643–6650, 2006. View at: Publisher Site | Google Scholar
  62. S. C. Langley-Evans, “Critical differences between two low protein diet protocols in the programming of hypertension in the rat,” International Journal of Food Sciences and Nutrition, vol. 51, no. 1, pp. 11–17, 2000. View at: Google Scholar
  63. D. J. P. Barker, “Fetal origins of coronary heart disease,” British Medical Journal, vol. 311, no. 6998, pp. 171–174, 1995. View at: Google Scholar
  64. M. Khoury, C. Manlhiot, S. Dobbin, D. Gibson, N. Chahal, and H. Wong, “Role of waist measures in characterizing the lipid and blood pressure assessment of adolescents classified by body mass index,” Archives of Pediatrics & Adolescent Medicine. In press. View at: Google Scholar
  65. C. Bertram, A. R. Trowern, N. Copin, A. A. Jackson, and C. B. Whorwood, “The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11β-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero,” Endocrinology, vol. 142, no. 7, pp. 2841–2853, 2001. View at: Publisher Site | Google Scholar
  66. D. S. Gardner, A. A. Jackson, and S. C. Langley-Evans, “Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids,” Hypertension, vol. 30, no. 6, pp. 1525–1530, 1997. View at: Google Scholar
  67. S. C. Langley-Evans, G. J. Phillips, R. Benediktsson et al., “Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat,” Placenta, vol. 17, no. 2-3, pp. 169–172, 1996. View at: Publisher Site | Google Scholar
  68. K. Tangalakis, E. R. Lumbers, K. M. Moritz, M. K. Towstoless, and E. M. Wintour, “Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus,” Experimental Physiology, vol. 77, no. 5, pp. 709–717, 1992. View at: Google Scholar
  69. C. R. W. Edwards, R. Benediktsson, R. S. Lindsay, and J. R. Seckl, “Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?” Lancet, vol. 341, no. 8841, pp. 355–357, 1993. View at: Publisher Site | Google Scholar
  70. E. M. Wintour, K. M. Moritz, K. Johnson, S. Ricardo, C. S. Samuel, and M. Dodic, “Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment,” Journal of Physiology, vol. 549, no. 3, pp. 929–935, 2003. View at: Publisher Site | Google Scholar
  71. C. B. Whorwood, M. L. Ricketts, and P. M. Stewart, “Regulation of sodium-potassium adenosine triphosphate subunit gene expression by corticosteroids and 11β-hydroxysteroid dehydrogenase activity,” Endocrinology, vol. 135, no. 3, pp. 901–910, 1994. View at: Publisher Site | Google Scholar
  72. C. B. Whorwood, K. M. Firth, H. Budge, and M. E. Symonds, “Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11β-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep,” Endocrinology, vol. 142, no. 7, pp. 2854–2864, 2001. View at: Publisher Site | Google Scholar
  73. F. F. Mesquita, J. A. R. Gontijo, and P. A. Boer, “Expression of renin-angiotensin system signalling compounds in maternal protein-restricted rats: effect on renal sodium excretion and blood pressure,” Nephrology Dialysis Transplantation, vol. 25, no. 2, pp. 380–388, 2010. View at: Publisher Site | Google Scholar
  74. H. C. Chou, L. F. Wang, K. S. Lu, and C. M. Chen, “Effects of maternal undernutrition on renal angiotensin II and chymase in hypertensive offspring,” Acta Histochemica, vol. 110, no. 6, pp. 497–504, 2008. View at: Publisher Site | Google Scholar
  75. G. Rivière, A. Michaud, C. Breton et al., “Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat,” Hypertension, vol. 46, no. 5, pp. 1169–1174, 2005. View at: Publisher Site | Google Scholar
  76. C. S. Wyrwoll, P. J. Mark, and B. J. Waddell, “Developmental programming of renal glucocorticoid sensitivity and the renin-angiotensin system,” Hypertension, vol. 50, no. 3, pp. 579–584, 2007. View at: Publisher Site | Google Scholar
  77. D. J. P. Barker, J. Gelow, K. Thornburg, C. Osmond, E. Kajantie, and J. G. Eriksson, “The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood,” European Journal of Heart Failure, vol. 12, no. 8, pp. 819–825, 2010. View at: Publisher Site | Google Scholar
  78. D. J. P. Barker, “Fetal programming of coronary heart disease,” Trends in Endocrinology and Metabolism, vol. 13, no. 9, pp. 364–368, 2002. View at: Publisher Site | Google Scholar
  79. J. G. Eriksson, T. Forsén, J. Tuomilehto, C. Osmond, and D. J. P. Barker, “Early growth and coronary heart disease in later life: longitudinal study,” British Medical Journal, vol. 322, no. 7292, pp. 949–953, 2001. View at: Google Scholar
  80. J. S. Yudkin, M. Kumari, S. E. Humphries, and V. Mohamed-Ali, “Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?” Atherosclerosis, vol. 148, no. 2, pp. 209–214, 2000. View at: Publisher Site | Google Scholar
  81. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at: Google Scholar
  82. R. Kleemann, S. Zadelaar, and T. Kooistra, “Cytokines and atherosclerosis: a comprehensive review of studies in mice,” Cardiovascular Research, vol. 79, no. 3, pp. 360–376, 2008. View at: Publisher Site | Google Scholar
  83. S. M. Grenon, J. Aguado-Zuniga, J. P. Hatton, C. D. Owens, M. S. Conte, and M. Hughes-Fulford, “Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion,” Journal of Surgical Research. In press. View at: Google Scholar
  84. G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang, “Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 5, pp. 265–274, 2003. View at: Publisher Site | Google Scholar
  85. Q. Xue, C. Dasgupta, M. Chen, and L. Zhang, “Foetal hypoxia increases cardiac AT2R expression and subsequent vulnerability to adult ischaemic injury,” Cardiovascular Research, vol. 89, no. 2, pp. 300–308, 2011. View at: Publisher Site | Google Scholar
  86. N. Soto, R. A. Bazaes, V. Peña et al., “Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3645–3650, 2003. View at: Publisher Site | Google Scholar
  87. L. Ibáñez, K. Ong, D. B. Dunger, and F. De Zegher, “Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2153–2158, 2006. View at: Publisher Site | Google Scholar
  88. S. Fabricius-Bjerre, R. B. Jensen, K. Færch et al., “Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence,” PLoS ONE, vol. 6, no. 6, article e20595, 2011. View at: Publisher Site | Google Scholar
  89. R. A. Bazaes and V. Mericq, “Premature birth and insulin resistance,” The New England Journal of Medicine, vol. 352, no. 9, pp. 939–940, 2005. View at: Publisher Site | Google Scholar
  90. P. M. Catalano, L. Presley, J. Minium, and S. H. D. Mouzon, “Fetuses of obese mothers develop insulin resistance in utero,” Diabetes Care, vol. 32, no. 6, pp. 1076–1080, 2009. View at: Publisher Site | Google Scholar
  91. A. Garofano, P. Czernichow, and B. Bréant, “In utero undernutrition impairs rat beta-cell development,” Diabetologia, vol. 40, no. 10, pp. 1231–1234, 1997. View at: Publisher Site | Google Scholar
  92. N. Theys, M. T. Ahn, T. Bouckenooghe, B. Reusens, and C. Remacle, “Maternal malnutrition programs pancreatic islet mitochondrial dysfunction in the adult offspring,” Journal of Nutritional Biochemistry, vol. 22, no. 10, pp. 985–994, 2011. View at: Publisher Site | Google Scholar
  93. K. Holemans, L. Aerts, and F. A. Van Assche, “Lifetime consequences of abnormal fetal pancreatic development,” Journal of Physiology, vol. 547, part 1, pp. 11–20, 2003. View at: Publisher Site | Google Scholar
  94. R. A. Simmons, “Developmental origins of diabetes: the role of epigenetic mechanisms,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 14, no. 1, pp. 13–16, 2007. View at: Publisher Site | Google Scholar
  95. P. Maechler, “Novel regulation of insulin secretion: the role of mitochondria,” Current Opinion in Investigational Drugs, vol. 4, no. 10, pp. 1166–1172, 2003. View at: Google Scholar
  96. B. Portha, A. Chavey, and J. Movassat, “Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass,” Experimental Diabetes Research, vol. 2011, Article ID 105076, 2011. View at: Google Scholar
  97. C. J. Zeng, L. Zhang, and H. X. Yang, “Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance,” Zhonghua Fu Chan Ke Za Zhi, vol. 45, no. 9, pp. 658–663, 2010. View at: Google Scholar
  98. P. D. Taylor, J. McConnell, I. Y. Khan et al., “Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 1, pp. R134–R139, 2005. View at: Publisher Site | Google Scholar
  99. F. Liu, Y. Xia, A. S. Parker, and I. M. Verma, “IKK biology,” Immunological Reviews, vol. 246, no. 1, pp. 239–253, 2012. View at: Google Scholar
  100. K. Sabapathy, “Role of the JNK pathway in human diseases,” Progress in Molecular Biology and Translational Science, vol. 106, pp. 145–169, 2012. View at: Google Scholar
  101. E. Rother, R. Kuschewski, M. A. Alcazar, A. Oberthuer, I. Bae-Gartz, and C. Vohlen, “Hypothalamic JNK1 and IKKbeta activation and impaired early postnatal glucose metabolism after maternal perinatal high-fat feeding,” Endocrinology, vol. 153, no. 2, pp. 770–781, 2012. View at: Google Scholar
  102. P. O. Prada, H. G. Zecchin, A. L. Gasparetti et al., “Western diet modulates insulin signaling, c-jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion,” Endocrinology, vol. 146, no. 3, pp. 1576–1587, 2005. View at: Publisher Site | Google Scholar
  103. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at: Publisher Site | Google Scholar
  104. M. Poggi, D. Bastelica, P. Gual et al., “C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet,” Diabetologia, vol. 50, no. 6, pp. 1267–1276, 2007. View at: Publisher Site | Google Scholar

Copyright © 2012 R. E. Fisher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.